Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China flag China · Delayed Price · Currency is CNY
16.15
-0.34 (-2.06%)
Nov 17, 2026, 3:04 PM CST

SHE:300204 Revenue

Staidson (Beijing) BioPharmaceuticals had revenue of 54.29M CNY in the quarter ending September 30, 2026, a decrease of -1.19%. This brings the company's total for the last twelve months to 186.88M, down -23.53% year-over-year. In the year 2025, Staidson (Beijing) BioPharmaceuticals had annual revenue of 220.23M, down -32.20%. That makes Staidson (Beijing) BioPharmaceuticals the 31,837th largest company in the world by revenue and 5,031st in China.

Revenue (ttm)
186.88M
Revenue Growth
-23.53%
P/S Ratio
47.97
Revenue / Employee
380.61K
Employees
491
Market Cap
8.74B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025220.23M-104.58M-32.20%
Dec 31, 2024324.82M-39.36M-10.81%
Dec 31, 2023364.18M-184.81M-33.66%
Jan 1, 2023548.99M-35.30M-6.04%
Dec 31, 2021584.29M159.08M37.41%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.